Year: 2026
Type: article
Study design: Case Report
Abstract: Duodenal and cutaneous metastases from rectal cancer are rare and associated with poor prognosis. This case report describes a patient with advanced rectal cancer who developed these uncommon metastases after first-line therapy. Upon treatment with fruquintinib, the patient experienced a rapid and significant regression of the cutaneous lesions, demonstrating a visible clinical response. This suggests that fruquintinib may be an effective therapeutic option for patients with such aggressive and rare metastatic disease.
Source: Frontiers in Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Award: G623238994
OpenAlex ID: W7135075404
